#WallStreetBets

beating my ass

 

AMC going to the moon or what?

 

elon musk's bullshit fucked my hvbtf holding

 

that sucks

 

i'm still up like 40% overall on it, but i'm dumping all that i own rn for a meager gain. i should've smartly sold it all when i was up almost 100%

 

yeah but what if you sold while up 100% and then it went up to 200%

 

yeah that's why i only purged half of my holdings when it was up 100%. why can't i just see the future so i don't have to make mistakes like this smh

 

GNCP announced some new acquisition the other day and it immediately caused the stock to plummet 30%.

 

For those still in $PPBT, why do you think the contacts changed at every NT219 clinical trial site? Also, adding a former VP at Teva with experience in Asia to the BOD is interesting

 

I don't know but I have 1200 shares that I'd like to see take off.

 

yeah i'm kinda pissed it dropped back down from $6, but i'm still holding. i don't know dick about the company though

 

I think they dropped today because they promised a chairman's letter for yesterday for days, then didn't release it.

 

Getting closer. Load the boat.

REHOVOT, Israel, May 20, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech”, or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, announced today that it will present new data from the ongoing Phase 1/2 clinical trial of NT219 on Friday, June 4, 2021, at the 2021 ASCO Annual Meeting, which will be held virtually from June 4-8.

 

$PPBT

bullish
“We are excited to present interim data from our ongoing Phase 1/2 clinical trial of NT219 as monotherapy for the treatment of solid tumors that has the potential to help people living with hard-to-treat cancers,” said Bertrand Liang, M.D., Ph.D., Chief Medical Officer of Purple Biotech. “We are excited to have clinical data for our NT219 program and we continue to expect the availability of further top-line data from the first part of this study in the second half of this year.”

 

What happened with PPBT in 2016

 

I can’t remember the details but it was explained on an investor’s board. If you’re talking about the CEO fucking up.

 

ok cool cool, looks like I did my research. BOUGHT.

 

I think you’re safe at these prices to make a decent profit. As always, the question is when to take profits. It was under $4 a week or so ago. Juicy.

 

I’m getting $Retc by one of his others plays. Fuck

 

SMAA will never wake up

 

I got in at 4.41 in late Jan... I’m selling at 6 if it gets there.

 

you dump your TGRR?

 

Anyone else still holding INCC? It’s up around 250% since Tuesday.

 

i'm wondering how long to hold CTXR bc it's up like 50% since i bought it

 

That’s a long hold. I got in at $1.55 and it’s been pretty reliable.

 

yeah i've already sold off a bunch, but i still have like another $1k or so worth that i'm wondering about just selling off

 

Still holding like 60 shares of ctxr but I have no idea where to expect it to go. I’ve already forgotten what their deal was, some medical tech innovations that haven’t hit yet, so long hold until that materializes.

 

If OTC is your reason for needing a different broker, don’t bother with E*TRADE. They are limiting otc trades September 1st.

 

Going to plug Schwab again for OTC

 

I've had zero issues with OTC trades

 

Haha yes I hope so too. I sold to cover my investment at the top and ditched the rest about halfway down. I’m glad I was able to pay close attention to it today.

 

So if SMAA doesn’t jump significantly before September I’m going have to eat around a 50% loss. Just fucking great, my god these last weeks have been so brutal

 

I wish that were my only otc bag

 

I only do this so I can take the losses on my taxes every year.

6d chess plebs

 

is anyone holding HPNN? it's been shit lately and i'm thinking of just cutting my losses